PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsRfviia
Rfviia
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
121 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hemophilia aD006467EFO_0007267D6619111561865
Blood coagulation disordersD001778EFO_0009314D68.91122631556
Hemostatic disordersD020141——1121631555
Hemophilia bD002836—D67149841143
HemorrhageD006470MP_0001914R58515521138
Postpartum hemorrhageD006473—O72———145
Deficiency diseasesD003677EFO_1001067E63———1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Cerebral hemorrhageD002543———82——10
Wounds and injuriesD014947—T14.8—32——5
Factor vii deficiencyD005168—D68.2211—25
Cardiac surgical proceduresD006348———11——2
Congenital heart defectsD006330—Q24.9——1——1
Heart diseasesD006331EFO_0003777I51.9——1——1
Hemorrhagic strokeD000083302————1——1
Coronary artery diseaseD003324—I25.1——1——1
Myocardial ischemiaD017202EFO_1001375I20-I25——1——1
Heart valve diseasesD006349EFO_0009551I08——1——1
Show 1 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ThrombastheniaD013915—D69.111——45
HematomaD006406EFO_0010680——1——12
Liver cirrhosisD008103EFO_0001422K74.0—2———2
Coronary diseaseD003327———1———1
Acute coronary syndromeD054058EFO_0005672——1———1
FeverD005334—R50.9—1———1
DengueD003715—A90—1———1
Severe dengueD019595—A91—1———1
Viral hemorrhagic feversD006482—A99—1———1
CystitisD003556EFO_1000025N30—1———1
Show 6 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients———9————9
Hemorrhagic disordersD006474—D69.91———12
HemostasisD006487——2————2
Intracranial hemorrhagesD020300EFO_0000551I621————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ThrombocytopeniaD013921HP_0001873D69.6————11
Cardiopulmonary bypassD002315——————11
Hemorrhagic shockD012771——————11
Traumatic brain hemorrhageD020201——————11
Factor xi deficiencyD005173—D68.1————11
ShockD012769—R57.1————11
Type 3 von willebrand diseaseD056729Orphanet_166096D68.03————11
Von willebrand diseasesD014842EFO_0003910D68.0————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
19 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use